10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001551152-20-000032 |
| Period End Date | 20200930 |
| Filing Date | 20201104 |
| Fiscal Year | 2020 |
| Fiscal Period | Q3 |
| XBRL Instance | abbv-20200930x10q_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, authorized (in shares) |
CommonStockSharesAuthorized
|
4.00B | shares | Point-in-time |
| Common stock, authorized (in shares) |
CommonStockSharesAuthorized
|
4.00B | shares | Point-in-time |
| Common stock, issued (in shares) |
CommonStockSharesIssued
|
1.79B | shares | Point-in-time |
| Cash and equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$7.89B | USD | Point-in-time |
| Cash and equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$39.92B | USD | Point-in-time |
| Common stock, issued (in shares) |
CommonStockSharesIssued
|
1.78B | shares | Point-in-time |
| Common stock held in treasury, at cost (in shares) |
TreasuryStockShares
|
302.67M | shares | Point-in-time |
| Common stock held in treasury, at cost (in shares) |
TreasuryStockShares
|
24.25M | shares | Point-in-time |
| Short-term investments |
ShortTermInvestments
|
- | USD | Point-in-time |
| Short-term investments |
ShortTermInvestments
|
$60.00M | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$5.43B | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$8.42B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$1.81B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$3.47B | USD | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssets
|
$3.17B | USD | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssets
|
$2.35B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$49.52B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$23.01B | USD | Point-in-time |
| Investments |
LongTermInvestments
|
$93.00M | USD | Point-in-time |
| Investments |
LongTermInvestments
|
$246.00M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.96B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.99B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$18.65B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$74.64B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$42.80B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$15.60B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$2.29B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$3.94B | USD | Point-in-time |
| Total assets |
Assets
|
$89.11B | USD | Point-in-time |
| Total assets |
Assets
|
$149.62B | USD | Point-in-time |
| Short-term borrowings |
ShortTermBorrowings
|
$54.00M | USD | Point-in-time |
| Short-term borrowings |
ShortTermBorrowings
|
- | USD | Point-in-time |
| Current portion of long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligationsCurrent
|
$4.72B | USD | Point-in-time |
| Current portion of long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligationsCurrent
|
$3.75B | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$11.83B | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$19.40B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$15.59B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$24.18B | USD | Point-in-time |
| Long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligations
|
$62.98B | USD | Point-in-time |
| Long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligations
|
$82.28B | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$4.49B | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$1.13B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$17.60B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$23.38B | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,789,544,701 shares issued as of September 30, 2020 and 1,781,582,608 as of December 31, 2019 |
CommonStockValueOutstanding
|
$18.00M | USD | Point-in-time |
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,789,544,701 shares issued as of September 30, 2020 and 1,781,582,608 as of December 31, 2019 |
CommonStockValueOutstanding
|
$18.00M | USD | Point-in-time |
| Common stock held in treasury, at cost, 24,250,071 shares as of September 30, 2020 and 302,671,146 as of December 31, 2019 |
TreasuryStockValue
|
$24.50B | USD | Point-in-time |
| Common stock held in treasury, at cost, 24,250,071 shares as of September 30, 2020 and 302,671,146 as of December 31, 2019 |
TreasuryStockValue
|
$1.97B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$17.15B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$15.19B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$3.33B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$4.72B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-3.26B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-3.60B | USD | Point-in-time |
| Total stockholders' equity (deficit) |
StockholdersEquity
|
$-8.17B | USD | Point-in-time |
| Total stockholders' equity (deficit) |
StockholdersEquity
|
$15.27B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
- | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$19.00M | USD | Point-in-time |
| Total equity (deficit) |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.73B | USD | Point-in-time |
| Total equity (deficit) |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.23B | USD | Point-in-time |
| Total equity (deficit) |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.57B | USD | Point-in-time |
| Total equity (deficit) |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.45B | USD | Point-in-time |
| Total equity (deficit) |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.17B | USD | Point-in-time |
| Total equity (deficit) |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.29B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$149.62B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$89.11B | USD | Point-in-time |
Income Statement
76 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net revenues |
Revenues
|
$31.95B | USD | 3 Qtrs |
| Net revenues |
Revenues
|
$12.90B | USD | 1 Quarter |
| Net revenues |
Revenues
|
$8.48B | USD | 1 Quarter |
| Net revenues |
Revenues
|
$24.56B | USD | 3 Qtrs |
| Cost of products sold |
CostOfGoodsAndServicesSold
|
$5.43B | USD | 3 Qtrs |
| Cost of products sold |
CostOfGoodsAndServicesSold
|
$1.92B | USD | 1 Quarter |
| Cost of products sold |
CostOfGoodsAndServicesSold
|
$5.05B | USD | 1 Quarter |
| Cost of products sold |
CostOfGoodsAndServicesSold
|
$10.70B | USD | 3 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$4.99B | USD | 3 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$8.07B | USD | 3 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.85B | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$1.66B | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$4.67B | USD | 3 Qtrs |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$2.29B | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$1.71B | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$4.87B | USD | 3 Qtrs |
| Acquired in-process research and development |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$246.00M | USD | 3 Qtrs |
| Acquired in-process research and development |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$45.00M | USD | 1 Quarter |
| Acquired in-process research and development |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$898.00M | USD | 3 Qtrs |
| Acquired in-process research and development |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
- | USD | 1 Quarter |
| Total operating costs and expenses |
CostsAndExpenses
|
$5.86B | USD | 1 Quarter |
| Total operating costs and expenses |
CostsAndExpenses
|
$9.65B | USD | 1 Quarter |
| Total operating costs and expenses |
CostsAndExpenses
|
$15.54B | USD | 3 Qtrs |
| Total operating costs and expenses |
CostsAndExpenses
|
$24.34B | USD | 3 Qtrs |
| Operating earnings |
OperatingIncomeLoss
|
$3.25B | USD | 1 Quarter |
| Operating earnings |
OperatingIncomeLoss
|
$2.62B | USD | 1 Quarter |
| Operating earnings |
OperatingIncomeLoss
|
$9.03B | USD | 3 Qtrs |
| Operating earnings |
OperatingIncomeLoss
|
$7.61B | USD | 3 Qtrs |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-1.05B | USD | 3 Qtrs |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-620.00M | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-1.66B | USD | 3 Qtrs |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-420.00M | USD | 1 Quarter |
| Net foreign exchange loss |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-54.00M | USD | 3 Qtrs |
| Net foreign exchange loss |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-31.00M | USD | 3 Qtrs |
| Net foreign exchange loss |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-19.00M | USD | 1 Quarter |
| Net foreign exchange loss |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-20.00M | USD | 1 Quarter |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-177.00M | USD | 1 Quarter |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-989.00M | USD | 3 Qtrs |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-115.00M | USD | 1 Quarter |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-2.59B | USD | 3 Qtrs |
| Earnings before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$4.91B | USD | 3 Qtrs |
| Earnings before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$5.35B | USD | 3 Qtrs |
| Earnings before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$2.50B | USD | 1 Quarter |
| Earnings before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$2.00B | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$271.00M | USD | 3 Qtrs |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$321.00M | USD | 3 Qtrs |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$187.00M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$117.00M | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$2.31B | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$5.08B | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$4.58B | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$1.88B | USD | 1 Quarter |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$5.00M | USD | 1 Quarter |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$4.00M | USD | 3 Qtrs |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$5.08B | USD | 3 Qtrs |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$1.88B | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$2.31B | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$4.58B | USD | 3 Qtrs |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$1.30 | USD | 1 Quarter |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$2.78 | USD | 3 Qtrs |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$1.27 | USD | 1 Quarter |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$3.41 | USD | 3 Qtrs |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$1.26 | USD | 1 Quarter |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$2.77 | USD | 3 Qtrs |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$1.29 | USD | 1 Quarter |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$3.41 | USD | 3 Qtrs |
| Weighted-average basic shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.48B | shares | 3 Qtrs |
| Weighted-average basic shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.77B | shares | 1 Quarter |
| Weighted-average basic shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.63B | shares | 3 Qtrs |
| Weighted-average basic shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.48B | shares | 1 Quarter |
| Weighted-average diluted shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.48B | shares | 1 Quarter |
| Weighted-average diluted shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.77B | shares | 1 Quarter |
| Weighted-average diluted shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.64B | shares | 3 Qtrs |
| Weighted-average diluted shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.48B | shares | 3 Qtrs |
Cash Flow Statement
86 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings |
ProfitLoss
|
$2.31B | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$5.08B | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$4.58B | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$1.88B | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$114.00M | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$346.00M | USD | 3 Qtrs |
| Depreciation |
Depreciation
|
$439.00M | USD | 3 Qtrs |
| Depreciation |
Depreciation
|
$175.00M | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$3.97B | USD | 3 Qtrs |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$1.16B | USD | 3 Qtrs |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$389.00M | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$2.10B | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-498.00M | USD | 3 Qtrs |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-77.00M | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$1.08B | USD | 3 Qtrs |
| Change in fair value of contingent consideration liabilities |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$2.65B | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$351.00M | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$617.00M | USD | 3 Qtrs |
| Upfront costs and milestones related to collaborations |
UpfrontCostsRelatedToCollaborations
|
$341.00M | USD | 3 Qtrs |
| Upfront costs and milestones related to collaborations |
UpfrontCostsRelatedToCollaborations
|
$1.03B | USD | 3 Qtrs |
| Intangible asset impairment |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
$1.03B | USD | 3 Qtrs |
| Intangible asset impairment |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 3 Qtrs |
| Other, net |
OtherNoncashIncomeExpense
|
$-491.00M | USD | 3 Qtrs |
| Other, net |
OtherNoncashIncomeExpense
|
$-92.00M | USD | 3 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$207.00M | USD | 3 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$574.00M | USD | 3 Qtrs |
| Inventories |
IncreaseDecreaseInInventories
|
$193.00M | USD | 3 Qtrs |
| Inventories |
IncreaseDecreaseInInventories
|
$401.00M | USD | 3 Qtrs |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$89.00M | USD | 3 Qtrs |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-190.00M | USD | 3 Qtrs |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$494.00M | USD | 3 Qtrs |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$1.90B | USD | 3 Qtrs |
| Income tax assets and liabilities, net |
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
$-298.00M | USD | 3 Qtrs |
| Income tax assets and liabilities, net |
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
$-727.00M | USD | 3 Qtrs |
| Cash flows from operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$12.73B | USD | 3 Qtrs |
| Cash flows from operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$10.05B | USD | 3 Qtrs |
| Acquisition of businesses, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
- | USD | 3 Qtrs |
| Acquisition of businesses, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$38.14B | USD | 3 Qtrs |
| Other acquisitions and investments |
PaymentsToAcquireOtherInvestments
|
$1.07B | USD | 3 Qtrs |
| Other acquisitions and investments |
PaymentsToAcquireOtherInvestments
|
$476.00M | USD | 3 Qtrs |
| Acquisitions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$389.00M | USD | 3 Qtrs |
| Acquisitions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$519.00M | USD | 3 Qtrs |
| Purchases of investment securities |
PaymentsToAcquireMarketableSecurities
|
$579.00M | USD | 3 Qtrs |
| Purchases of investment securities |
PaymentsToAcquireMarketableSecurities
|
$47.00M | USD | 3 Qtrs |
| Sales and maturities of investment securities |
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
$1.46B | USD | 3 Qtrs |
| Sales and maturities of investment securities |
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
$2.65B | USD | 3 Qtrs |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
- | USD | 3 Qtrs |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-1.38B | USD | 3 Qtrs |
| Cash flows from investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-36.93B | USD | 3 Qtrs |
| Cash flows from investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$1.21B | USD | 3 Qtrs |
| Net change in commercial paper borrowings |
ProceedsFromRepaymentsOfCommercialPaper
|
$-699.00M | USD | 3 Qtrs |
| Net change in commercial paper borrowings |
ProceedsFromRepaymentsOfCommercialPaper
|
- | USD | 3 Qtrs |
| Repayments of other short-term borrowings |
RepaymentsOfOtherShortTermDebt
|
$3.00B | USD | 3 Qtrs |
| Repayments of other short-term borrowings |
RepaymentsOfOtherShortTermDebt
|
- | USD | 3 Qtrs |
| Proceeds from issuance of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$3.00B | USD | 3 Qtrs |
| Proceeds from issuance of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$1.53B | USD | 3 Qtrs |
| Repayments of long-term debt and finance lease obligations |
RepaymentsOfLongTermDebtAndCapitalSecurities
|
$5.00M | USD | 3 Qtrs |
| Repayments of long-term debt and finance lease obligations |
RepaymentsOfLongTermDebtAndCapitalSecurities
|
$4.41B | USD | 3 Qtrs |
| Repayments of long-term debt and finance lease obligations |
PaymentOfFinancingAndStockIssuanceCosts
|
$20.00M | USD | 3 Qtrs |
| Repayments of long-term debt and finance lease obligations |
PaymentOfFinancingAndStockIssuanceCosts
|
$248.00M | USD | 3 Qtrs |
| Dividends paid |
PaymentsOfDividends
|
$5.62B | USD | 3 Qtrs |
| Dividends paid |
PaymentsOfDividends
|
$4.77B | USD | 3 Qtrs |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$627.00M | USD | 3 Qtrs |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$682.00M | USD | 3 Qtrs |
| Proceeds from the exercise of stock options |
ProceedsFromStockOptionsExercised
|
$6.00M | USD | 3 Qtrs |
| Proceeds from the exercise of stock options |
ProceedsFromStockOptionsExercised
|
$109.00M | USD | 3 Qtrs |
| Payments of contingent consideration liabilities |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
$120.00M | USD | 3 Qtrs |
| Payments of contingent consideration liabilities |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
$212.00M | USD | 3 Qtrs |
| Other, net |
ProceedsFromPaymentsForOtherFinancingActivities
|
$36.00M | USD | 3 Qtrs |
| Other, net |
ProceedsFromPaymentsForOtherFinancingActivities
|
$28.00M | USD | 3 Qtrs |
| Cash flows from financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-7.81B | USD | 3 Qtrs |
| Cash flows from financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-7.89B | USD | 3 Qtrs |
| Effect of exchange rate changes on cash and equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$-7.00M | USD | 3 Qtrs |
| Effect of exchange rate changes on cash and equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$-32.00M | USD | 3 Qtrs |
| Net change in cash and equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$3.36B | USD | 3 Qtrs |
| Net change in cash and equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-32.03B | USD | 3 Qtrs |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.65B | USD | Point-in-time |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$7.89B | USD | Point-in-time |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$39.92B | USD | Point-in-time |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$7.29B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.65B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$7.89B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$39.92B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$7.29B | USD | Point-in-time |
| Issuance of common shares associated with acquisitions of businesses |
StockIssued1
|
- | USD | 3 Qtrs |
| Issuance of common shares associated with acquisitions of businesses |
StockIssued1
|
$23.98B | USD | 3 Qtrs |
Stockholders Equity
35 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.73B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.23B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.57B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.45B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.17B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.29B | USD | Point-in-time |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$5.08B | USD | 3 Qtrs |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$1.88B | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$2.31B | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$4.58B | USD | 3 Qtrs |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$176.00M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-48.00M | USD | 3 Qtrs |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-37.00M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$337.00M | USD | 3 Qtrs |
| Dividends declared |
DividendsCommonStockCash
|
$4.78B | USD | 3 Qtrs |
| Dividends declared |
DividendsCommonStockCash
|
$1.59B | USD | 1 Quarter |
| Dividends declared |
DividendsCommonStockCash
|
$2.10B | USD | 1 Quarter |
| Dividends declared |
DividendsCommonStockCash
|
$5.96B | USD | 3 Qtrs |
| Common shares and equity awards issued for acquisition of Allergan plc |
StockIssuedDuringPeriodValueAcquisitions
|
$24.41B | USD | 3 Qtrs |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$682.00M | USD | 3 Qtrs |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$425.00M | USD | 3 Qtrs |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$20.00M | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$3.00M | USD | 1 Quarter |
| Stock-based compensation plans and other |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$201.00M | USD | 1 Quarter |
| Stock-based compensation plans and other |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$91.00M | USD | 1 Quarter |
| Stock-based compensation plans and other |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$760.00M | USD | 3 Qtrs |
| Stock-based compensation plans and other |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$388.00M | USD | 3 Qtrs |
| Change in noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$19.00M | USD | 3 Qtrs |
| Change in noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$-5.00M | USD | 1 Quarter |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.73B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.23B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.57B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.45B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-8.17B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.29B | USD | Point-in-time |
Comprehensive Income
60 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Foreign currency translation adjustments, tax expense (benefit) |
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
$-10.00M | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$2.31B | USD | 1 Quarter |
| Foreign currency translation adjustments, tax expense (benefit) |
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
$15.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, tax expense (benefit) |
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
$-16.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, tax expense (benefit) |
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
$11.00M | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$5.08B | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$4.58B | USD | 3 Qtrs |
| Net earnings |
ProfitLoss
|
$1.88B | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax expense (benefit) of $15 for the three months and $11 for the nine months ended September 30, 2020 and $(16) for the three months and $(10) for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$512.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax expense (benefit) of $15 for the three months and $11 for the nine months ended September 30, 2020 and $(16) for the three months and $(10) for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$726.00M | USD | 3 Qtrs |
| Net investment hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
|
$-85.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax expense (benefit) of $15 for the three months and $11 for the nine months ended September 30, 2020 and $(16) for the three months and $(10) for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-288.00M | USD | 3 Qtrs |
| Foreign currency translation adjustments, net of tax expense (benefit) of $15 for the three months and $11 for the nine months ended September 30, 2020 and $(16) for the three months and $(10) for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-256.00M | USD | 1 Quarter |
| Net investment hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
|
$53.00M | USD | 3 Qtrs |
| Net investment hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
|
$-125.00M | USD | 3 Qtrs |
| Net investment hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
|
$45.00M | USD | 1 Quarter |
| Net investment hedging activities, net of tax expense (benefit) of $(85) for the three months and $(125) for the nine months ended September 30, 2020 and $45 for the three months and $53 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
|
$-455.00M | USD | 3 Qtrs |
| Net investment hedging activities, net of tax expense (benefit) of $(85) for the three months and $(125) for the nine months ended September 30, 2020 and $45 for the three months and $53 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
|
$-314.00M | USD | 1 Quarter |
| Net investment hedging activities, net of tax expense (benefit) of $(85) for the three months and $(125) for the nine months ended September 30, 2020 and $45 for the three months and $53 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
|
$156.00M | USD | 1 Quarter |
| Net investment hedging activities, net of tax expense (benefit) of $(85) for the three months and $(125) for the nine months ended September 30, 2020 and $45 for the three months and $53 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
|
$184.00M | USD | 3 Qtrs |
| Pension and post-employment benefits, tax expense (benefit) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
$-37.00M | USD | 3 Qtrs |
| Pension and post-employment benefits, tax expense (benefit) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
$-10.00M | USD | 1 Quarter |
| Pension and post-employment benefits, tax expense (benefit) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
$-7.00M | USD | 1 Quarter |
| Pension and post-employment benefits, tax expense (benefit) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
$-19.00M | USD | 3 Qtrs |
| Marketable security activities, tax expense (benefit) |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
- | USD | 3 Qtrs |
| Marketable security activities, tax expense (benefit) |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
- | USD | 1 Quarter |
| Pension and post-employment benefits, net of tax expense (benefit) of $10 for the three months and $37 for the nine months ended September 30, 2020 and $7 for the three months and $19 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-134.00M | USD | 3 Qtrs |
| Pension and post-employment benefits, net of tax expense (benefit) of $10 for the three months and $37 for the nine months ended September 30, 2020 and $7 for the three months and $19 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-33.00M | USD | 1 Quarter |
| Marketable security activities, tax expense (benefit) |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
- | USD | 3 Qtrs |
| Pension and post-employment benefits, net of tax expense (benefit) of $10 for the three months and $37 for the nine months ended September 30, 2020 and $7 for the three months and $19 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-35.00M | USD | 1 Quarter |
| Marketable security activities, tax expense (benefit) |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
- | USD | 1 Quarter |
| Pension and post-employment benefits, net of tax expense (benefit) of $10 for the three months and $37 for the nine months ended September 30, 2020 and $7 for the three months and $19 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-78.00M | USD | 3 Qtrs |
| Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the nine months ended September 30, 2020 and $ for the three months and $ for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
$10.00M | USD | 3 Qtrs |
| Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the nine months ended September 30, 2020 and $ for the three months and $ for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
- | USD | 3 Qtrs |
| Cash flow hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
$-9.00M | USD | 1 Quarter |
| Cash flow hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
$9.00M | USD | 3 Qtrs |
| Cash flow hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
$-13.00M | USD | 3 Qtrs |
| Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the nine months ended September 30, 2020 and $ for the three months and $ for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
$-1.00M | USD | 1 Quarter |
| Cash flow hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
$18.00M | USD | 1 Quarter |
| Marketable security activities, net of tax expense (benefit) of $ for the three months and $ for the nine months ended September 30, 2020 and $ for the three months and $ for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
- | USD | 1 Quarter |
| Cash flow hedging activities, net of tax expense (benefit) of $(9) for the three months and $(13) for the nine months ended September 30, 2020 and $18 for the three months and $9 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
$31.00M | USD | 1 Quarter |
| Cash flow hedging activities, net of tax expense (benefit) of $(9) for the three months and $(13) for the nine months ended September 30, 2020 and $18 for the three months and $9 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
$-57.00M | USD | 1 Quarter |
| Cash flow hedging activities, net of tax expense (benefit) of $(9) for the three months and $(13) for the nine months ended September 30, 2020 and $18 for the three months and $9 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
$-32.00M | USD | 3 Qtrs |
| Cash flow hedging activities, net of tax expense (benefit) of $(9) for the three months and $(13) for the nine months ended September 30, 2020 and $18 for the three months and $9 for the nine months ended September 30, 2019 |
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
|
$-68.00M | USD | 3 Qtrs |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$176.00M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-48.00M | USD | 3 Qtrs |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-37.00M | USD | 1 Quarter |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$337.00M | USD | 3 Qtrs |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$2.49B | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$1.85B | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$5.03B | USD | 3 Qtrs |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$4.92B | USD | 3 Qtrs |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$4.00M | USD | 3 Qtrs |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 3 Qtrs |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
- | USD | 1 Quarter |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$5.00M | USD | 1 Quarter |
| Comprehensive income attributable to AbbVie Inc. |
ComprehensiveIncomeNetOfTax
|
$1.85B | USD | 1 Quarter |
| Comprehensive income attributable to AbbVie Inc. |
ComprehensiveIncomeNetOfTax
|
$4.92B | USD | 3 Qtrs |
| Comprehensive income attributable to AbbVie Inc. |
ComprehensiveIncomeNetOfTax
|
$5.03B | USD | 3 Qtrs |
| Comprehensive income attributable to AbbVie Inc. |
ComprehensiveIncomeNetOfTax
|
$2.48B | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.